+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variability in intrahepatic iron concentration in end-stage liver disease due to hepatitis C



Variability in intrahepatic iron concentration in end-stage liver disease due to hepatitis C



Hepatology 24(4 Part 2): 299A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034181448

Download citation: RISBibTeXText


Related references

Hepatic iron concentration in end stage liver disease 2-0 to chronic hepatitis C and/or alcoholic liver disease. Hepatology 22(4 Part 2): 275A, 1995

Significance of hepatic iron concentration in patients with end-stage liver disease secondary to chronic hepatitis C infection. Gastroenterology 110(4 Suppl. ): A1157, 1996

Phenotype characterisation of intrahepatic T, NKT and NK cells in liver transplant recipients with end-stage hepatitis C related liver disease. Hepatology 36(4 Part 2): 538A, 2002

Low hepatic iron concentration determination Variability of colorimetric assay and iron histological scoring in patients with chronic hepatitis C. Hepatology 24(4 Part 2): 495A, 1996

Significant iron overload is common in end-stage liver disease associated with chronic hepatitis B and is related to nuclear HBcAg expression. Hepatology 32(4 Pt 2): 454A, 2000

Survival after liver transplantation for hepatocellular carcinoma in the model for end-stage liver disease and pre-model for end-stage liver disease eras and the independent impact of hepatitis C virus. Liver Transplantation 15(7): 754-762, 2009

Model for end-stage liver disease limbo, model for end-stage liver disease purgatory, and the dilemma of treating hepatitis C in patients awaiting liver transplantation. Liver Transplantation 22(3): 279-280, 2016

Hepatitis C virus RNA quantitation in hepatic veins and peripheral blood in patients with liver cirrhosis: Evidence for low level intrahepatic hepatitis C virus replication in advanced liver disease. Digestive & Liver Disease 34(11): 802-807, 2002

Hepatitis C virus RNA quantitation in hepatic veins and peripheral blood in patients with liver cirrhosis: evidence for low level intrahepatic hepatitis C virus replication in advanced liver disease. Digestive and Liver Disease 34(11): 802-807, 2003

Mayo end-stage liver disease score Causes of variability in patients with end-stage liver disease. Gastroenterology 120(5 Suppl. 1): A 371, 2001

Hepatic iron concentration in tumor and non-tumor tissue in patients with end-stage liver disease and hepatocellular carcinoma. Hepatology 30(4 Part 2): 282A, 1999

Phenotyping of intrahepatic T, NKT and NK cells in liver transplant recipients with end-stage alcohol related chronic liver disease. Hepatology 36(4 Part 2): 408A, 2002

Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15. Digestive Diseases and Sciences 62(2): 534-542, 2016

Intra-organ variability of hepatic iron concentration with hepatitis C. Hepatology 22(4 Part 2): 276A, 1995

Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver. Gastroenterologia Y Hepatologia 28(6): 364, 2005